RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Pharmaceutical Industry

A collection of news and information related to Pharmaceutical Industry published by this site and its partners.

Top Pharmaceutical Industry Articles

Displaying items 45-55
  • Air Products' investor Ackman had profitable 2014

    Billionaire activist investor William Ackman, who holds a major stake in Trexlertown-based Air Products, came in fourth last year among the top 25 hedge fund managers in the country, according to annual ranking published Tuesday by Institutional Investor'...
  • U.S. prescription drug spending jumps to record $374 billion

    U.S. prescription drug spending jumps to record $374 billion
    U.S. spending on prescription drugs soared last year, driven up primarily by costly breakthrough medicines, manufacturer price hikes and a surge from millions of people newly insured due to the Affordable Care Act. Spending rose 13 percent, the...
  • Why the execution drug shortage won't go away

    Why the execution drug shortage won't go away
    In a few weeks, the U.S. Supreme Court will hear Glossip vs. Gross, which examines the use of the drug midazolam in lethal injection executions. The case comes on the heels of an infamously gruesome 2014, a year that saw botched executions in Ohio,...
  • FDA: Hospira's corrective actions at Italy plant weren't enough

     FDA: Hospira's corrective actions at Italy plant weren't enough
    The Food and Drug Administration has warned Hospira that corrective actions the drugmaker made at an Italy facility weren't sufficient, the company disclosed Tuesday in a regulatory filing. The FDA in a March 31 letter said Hospira lacked written...
  • Bill on drug pricing would help state in figuring healthcare costs

    Bill on drug pricing would help state in figuring healthcare costs
    A new crop of specialty drugs holds great promise for treating or even curing some devastating diseases, but their high cost challenges health insurers and taxpayer-funded health programs. In California, Gov. Jerry Brown has asked for $300 million in...
  • Early sales of MannKind inhaled insulin drug disappoint Wall Street

    Early sales of MannKind inhaled insulin drug disappoint Wall Street
    Early sales of MannKind Corp.'s new inhaled insulin drug were less than expected, and the Valencia company's stock skidded to near a one-year low. French pharmaceutical company Sanofi, which is marketing the drug, Afrezza, in a partnership with...
  • FDA approves Westlake Village company's drug to reduce double-chin fat

    FDA approves Westlake Village company's drug to reduce double-chin fat
    The Food and Drug Administration has approved a Westlake Village company's injectable drug as a treatment to reduce double-chin fat in adults. Kythera Biopharmaceuticals Inc. said in a news release that injections of the drug have been shown in clinical...
  • Address drug abuse and access together: My Word

     Address drug abuse and access together: My Word
    In one household, a family is devastated by prescription-drug abuse. While in another, a patient can't understand why he is denied the pain medications needed to make life bearable. Both scenarios are heartbreaking, and different, but also tied...
  • Hospira earnings rise 11 percent with Pfizer deal pending

    Hospira earnings rise 11 percent with Pfizer deal pending
    Injectable drugs company Hospira reported first-quarter 2015 results Tuesday that beat expectations. Pharmaceutical giant Pfizer offered to buy the Lake Forest company in February for about $15.23 billion. Here's a snapshot of the quarter, and a bit...
  • Taxpayers' Costs For Unregulated Drug Prescriptions Explode By 3,000% In Three Years

    Taxpayers' Costs For Unregulated Drug Prescriptions Explode By 3,000% In Three Years
    Unregulated drugs produced by controversial compounding pharmacies are costing Connecticut taxpayers up to $24 million this year in prescription payments on behalf of state employees and retirees, a stunning 3,000 percent increase from their $800,000...
  • Abbott first quarter earnings boosted to $2.29B by divestitures

    Abbott first quarter earnings boosted to $2.29B by divestitures
    Health care products and pharmaceuticals company Abbott Laboratories reported first-quarter 2015 results Wednesday marked by two big sales that boosted earnings while beating sales growth. A snapshot of the quarter, and a bit on what's to come: By the...